PT2680873T - Agentes antifúngicos e suas utilizações - Google Patents

Agentes antifúngicos e suas utilizações

Info

Publication number: PT2680873T
Authority: PT; Portugal
Prior art keywords: antifungal agents; antifungal; agents
Prior art date: 2011-03-03

Application number

PT127519940T

Other languages

English (en)

Inventor

Duke James Kenneth Jr

Patrick Laudeman Christopher

Balkrishna Malkar Navdeep

Radhakrishnan Balasingham

Original Assignee

Cidara Therapeutics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-03-03

Filing date

2012-03-02

Publication date

2017-11-01

2012-03-02 Application filed by Cidara Therapeutics Inc filed Critical Cidara Therapeutics Inc

2017-11-01 Publication of PT2680873T publication Critical patent/PT2680873T/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Oncology (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Pulmonology (AREA)
Hematology (AREA)
Otolaryngology (AREA)
Dermatology (AREA)
Urology & Nephrology (AREA)
Gynecology & Obstetrics (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PT127519940T 2011-03-03 2012-03-02 Agentes antifúngicos e suas utilizações PT2680873T (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US201161448807P	2011-03-03	2011-03-03

Publications (1)

Publication Number	Publication Date
PT2680873T true PT2680873T (pt)	2017-11-01

Family

ID=46758514

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT127519940T PT2680873T (pt)	2011-03-03	2012-03-02	Agentes antifúngicos e suas utilizações

Country Status (21)

Country	Link
US (6)	US8722619B2 (pt)
EP (2)	EP3192803B1 (pt)
JP (4)	JP5809296B2 (pt)
CN (2)	CN106279369B (pt)
CA (2)	CA2865791C (pt)
CY (2)	CY1119709T1 (pt)
DK (1)	DK2680873T3 (pt)
ES (1)	ES2645074T3 (pt)
FI (1)	FIC20240022I1 (pt)
FR (1)	FR24C1027I2 (pt)
HR (1)	HRP20171579T8 (pt)
HU (2)	HUE036778T2 (pt)
LT (2)	LT2680873T (pt)
NL (1)	NL301280I2 (pt)
NO (1)	NO2680873T3 (pt)
PL (1)	PL2680873T3 (pt)
PT (1)	PT2680873T (pt)
RS (1)	RS56426B1 (pt)
SI (1)	SI2680873T1 (pt)
SM (1)	SMT201700460T1 (pt)
WO (1)	WO2012119065A2 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SI2680873T1 (sl)	2011-03-03	2017-12-29	Cidara Therapeutics, Inc.	Protiglivna sredstva in njihova uporaba
PL3677252T3 (pl) *	2012-03-19	2024-01-08	Cidara Therapeutics, Inc.	Schematy dawkowania dla związków z klasy echinokandyn
WO2015035102A2 (en) *	2013-09-04	2015-03-12	Cidara Therapeutics, Inc.	Compositions and methods for the treatment of fungal infections
EP3136864A4 (en) *	2014-04-28	2017-12-27	University of Central Florida Research Foundation, Inc.	Compositions, methods of making a composition, and methods of use
WO2016201283A1 (en) *	2015-06-12	2016-12-15	Cidara Therapeutics, Inc.	Antifungal agents
US20180256673A1 (en) *	2015-09-16	2018-09-13	Cidara Therapeutics, Inc.	Methods for treating fungal infections
CN106674333B (zh) *	2015-11-06	2020-10-27	博瑞生物医药（苏州）股份有限公司	一种环肽类抗真菌化合物及其制备方法
CN108883152A (zh) *	2016-01-08	2018-11-23	奇达拉治疗公司	防止和治疗肺孢子虫感染的方法
ES2955711T3 (es) *	2016-03-16	2023-12-05	Cidara Therapeutics Inc	Regímenes de dosificación para el tratamiento de infecciones fúngicas
EP3512539A4 (en)	2016-09-13	2020-07-29	Prothera Biologics, Inc.	METHODS FOR TREATING LUNG DISEASE USING INTER-ALPHA INHIBITOR PROTEINS
WO2018102407A1 (en) *	2016-11-29	2018-06-07	Cidara Therapeutics, Inc	Methods for preventing fungal infections
MA47437A (fr) *	2017-01-31	2019-12-11	Cidara Therapeutics Inc	Procédés de traitement d'infections fongiques
CA3061164A1 (en)	2017-04-25	2018-11-01	Prothera Biologics, Inc.	Methods for quantifying inter-alpha inhibitor proteins
CN111050798A (zh) *	2017-07-12	2020-04-21	奇达拉治疗公司	用于治疗真菌感染的组合物和方法
CN112839951B (zh) *	2018-06-15	2025-12-09	纳普制药集团有限公司	棘白菌素类抗真菌剂的合成
WO2020086931A1 (en) *	2018-10-25	2020-04-30	Cidara Therapeutics, Inc.	Polymorph of echinocandin antifungal agent
MX2022006424A (es)	2019-12-06	2022-06-22	Shanghai Senhui Medicine Co Ltd	Analogos de equinocandina y metodo de preparacion de los mismos.
TW202313656A (zh)	2021-06-03	2023-04-01	大陸商上海森輝醫藥有限公司	一種阿尼芬淨衍生物的製備方法
CN115850383A (zh) *	2022-12-15	2023-03-28	江苏九阳生物制药有限公司	一种雷扎芬净纯化方法
CN116903706B (zh) *	2023-06-13	2024-05-17	深圳市祥根生物有限公司	一种棘白菌素类药物及其制备方法和用途

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4427660A (en)	1982-03-03	1984-01-24	Research Corporation	Formyl-methionyl chemotatic peptide antibiotic conjugates useful in treating infections
US5166135A (en)	1988-09-12	1992-11-24	Merck & Company, Inc.	Method for the control of pneumocystis carinii
US6030944A (en) *	1991-10-01	2000-02-29	Merck & Co., Inc.	Cyclohexapeptidyl bisamine compounds
US5399552A (en)	1991-10-17	1995-03-21	Merck & Co, Inc	Antibiotic peptides bearing aminoalkylthioether moieties
US5378804A (en)	1993-03-16	1995-01-03	Merck & Co., Inc.	Aza cyclohexapeptide compounds
US6268338B1 (en)	1993-04-30	2001-07-31	Merck & Co., Inc.	Cyclohexapeptidyl amine compounds
US5948753A (en)	1993-05-04	1999-09-07	Merck & Co., Inc.	Cyclohexapeptidyl propanolamine compounds
JPH09500103A (ja) *	1993-05-04	1997-01-07	メルクエンドカンパニーインコーポレーテッド	シクロヘキサペプチジルアミノアルキルエーテル
WO1995008341A1 (en) *	1993-09-22	1995-03-30	Merck & Co., Inc.	Antifungal and anti-pneumocystis compounds, compositions containing such compounds, and methods of use
US5541160A (en) *	1994-04-04	1996-07-30	Merck & Co., Inc.	Antifungal and anti-pneumocystis compounds, compositions containing such compounds, and methods of use
US5514651A (en)	1994-09-16	1996-05-07	Merck & Co., Inc.	Aza cyclohexapeptide compounds
US5516756A (en)	1994-10-31	1996-05-14	Merck & Co., Inc.	Aza cyclohexapeptide compounds
DE69615535T2 (de)	1995-01-26	2002-05-02	Merck & Co., Inc.	Neue fungizide cyclohexapeptide
US5652213A (en) *	1995-05-26	1997-07-29	Eli Lilly And Company	Cyclic peptide antifungal agents
AR006598A1 (es)	1996-04-19	1999-09-08	Merck Sharp & Dohme	"composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación"
US6069126A (en)	1996-09-12	2000-05-30	Merck & Co., Inc.	Antifungal combination therapy
JP2003511345A (ja) *	1998-12-09	2003-03-25	イーライリリーアンドカンパニー	Ｅｃｈｉｎｏｃａｎｄｉｎシクロペプチド化合物の精製
US6248363B1 (en)	1999-11-23	2001-06-19	Lipocine, Inc.	Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
RU2250763C2 (ru)	1999-03-03	2005-04-27	Эли Лилли Энд Компани	Фармацевтические препараты эхинокандина, содержащие мицелообразующие поверхностно-активные вещества
BR0008713A (pt)	1999-03-03	2001-12-26	Lilly Co Eli	Processos para preparar formulações ecomposições farmacêuticas orais com ecb
US6309622B1 (en)	1999-03-26	2001-10-30	Protech Professional Products, Inc.	Antimicrobial denture cleansing compositions
CN1355699A (zh)	1999-04-16	2002-06-26	藤泽药品工业株式会社	抗真菌组合物
US6610822B2 (en)	2000-09-01	2003-08-26	Merck & Co., Inc.	Purification process
HU0104790D0 (en)	2001-11-08	2002-01-28	Human Rt	Pharmaceutical combinations for topical application
US6991800B2 (en)	2002-06-13	2006-01-31	Vicuron Pharmaceuticals Inc.	Antifungal parenteral products
US20060276339A1 (en)	2002-10-16	2006-12-07	Windsor J B	Methods and compositions for increasing the efficacy of biologically-active ingredients
US6913759B2 (en)	2003-03-11	2005-07-05	Curatek Pharmaceuticals Holding, Inc.	Gel composition and method for treatment of vaginal infections
ATE381957T1 (de)	2003-07-22	2008-01-15	Theravance Inc	Verwendung eines antimykotischen echinocandin- mittels in kombination mit einem antibakteriellen glycopeptid-mittel
US20060140990A1 (en)	2003-09-19	2006-06-29	Drugtech Corporation	Composition for topical treatment of mixed vaginal infections
AU2006272568B2 (en)	2005-07-26	2012-06-28	Merck Sharp & Dohme Corp.	Assays for resistance to echinocandin-class drugs
WO2007113386A1 (en) *	2006-03-31	2007-10-11	Karyon-Ctt Ltd	Peptide conjugates
GB0702020D0 (en)	2007-02-02	2007-03-14	Novabiotics Ltd	Peptides and their use
US20090238867A1 (en)	2007-12-13	2009-09-24	Scott Jenkins	Nanoparticulate Anidulafungin Compositions and Methods for Making the Same
US20100009009A1 (en)	2008-07-10	2010-01-14	Micropure, Inc.	Method and composition for prevention and treatment of oral fungal infections
GB0817121D0 (en)	2008-09-18	2008-10-29	Univ St Andrews	Anti-fungal therapy
US10568859B2 (en)	2009-02-25	2020-02-25	Mayne Pharma Llc	Topical foam composition
ES2461596T3 (es) *	2009-05-07	2014-05-20	Dsm Sinochem Pharmaceuticals Netherlands B.V.	Método para la preparación de ciclopéptidos
CA2772294C (en)	2009-08-26	2018-08-21	Guy M. Miller	Methods for the prevention and treatment of cerebral ischemia
EP2470190A4 (en)	2009-08-27	2013-07-17	Seachaid Pharmaceuticals Inc	ECHINOCANDINDERIVATE
US9561285B2 (en)	2010-01-22	2017-02-07	Ascendis Pharma As	Carrier-linked carbamate prodrug linkers
SI2680873T1 (sl)	2011-03-03	2017-12-29	Cidara Therapeutics, Inc.	Protiglivna sredstva in njihova uporaba
WO2013017691A1 (en)	2011-08-04	2013-02-07	Medizinische Universität Innsbruck	Cahgt1p inhibitors for use in the treatment of candidiasis
US8829053B2 (en)	2011-12-07	2014-09-09	Rochal Industries Llp	Biocidal compositions and methods of using the same
PL3677252T3 (pl)	2012-03-19	2024-01-08	Cidara Therapeutics, Inc.	Schematy dawkowania dla związków z klasy echinokandyn
CN102766198A (zh)	2012-05-04	2012-11-07	中国人民解放军第二军医大学	一种糖肽类抗真菌化合物及其制备方法与应用
US20150320675A1 (en)	2013-01-18	2015-11-12	University Of Utah Research Foundation	Modified Release Osmotic Pump for PH-Responsive Drug Delivery
WO2014124504A1 (en)	2013-02-13	2014-08-21	Katholieke Universiteit Leuven Ku Leuven Research & Development	Compositions and methods for treating biofilms
US9919055B2 (en)	2013-03-15	2018-03-20	Arizona Board Of Regents On Behalf Of Arizona State University	Sugar-linker-drug conjugates
EP2991638B1 (en)	2013-05-01	2019-06-26	Neoculi Pty Ltd	Methods for treating bacterial infections
WO2015035102A2 (en)	2013-09-04	2015-03-12	Cidara Therapeutics, Inc.	Compositions and methods for the treatment of fungal infections
US20180256673A1 (en)	2015-09-16	2018-09-13	Cidara Therapeutics, Inc.	Methods for treating fungal infections
WO2017049105A1 (en)	2015-09-16	2017-03-23	Cidara Therapeutics, Inc.	Formulations for treating fungal infections
CN108883152A (zh)	2016-01-08	2018-11-23	奇达拉治疗公司	防止和治疗肺孢子虫感染的方法
ES2955711T3 (es)	2016-03-16	2023-12-05	Cidara Therapeutics Inc	Regímenes de dosificación para el tratamiento de infecciones fúngicas
EP3534927A4 (en)	2016-11-01	2020-07-29	Cidara Therapeutics, Inc.	SINGLE-DOSE METHODS FOR THE PREVENTION AND TREATMENT OF FUNGAL INFECTIONS
WO2018102407A1 (en)	2016-11-29	2018-06-07	Cidara Therapeutics, Inc	Methods for preventing fungal infections
MA47437A (fr)	2017-01-31	2019-12-11	Cidara Therapeutics Inc	Procédés de traitement d'infections fongiques
WO2018187574A1 (en)	2017-04-05	2018-10-11	Cidara Therapeutics, Inc.	Compositions and methods for the treatment of fungal infections
WO2018191692A1 (en)	2017-04-14	2018-10-18	Cidara Therapeutics, Inc.	Methods for treating fungal infections
CN111050798A (zh)	2017-07-12	2020-04-21	奇达拉治疗公司	用于治疗真菌感染的组合物和方法
US20200164023A1 (en)	2017-08-03	2020-05-28	Cidara Therapeutics, Inc.	Methods for preventing and treating intra-abdominal candidiasis
CN112839951B (zh)	2018-06-15	2025-12-09	纳普制药集团有限公司	棘白菌素类抗真菌剂的合成

2012
- 2012-03-02 SI SI201231096T patent/SI2680873T1/sl unknown
- 2012-03-02 SM SM20170460T patent/SMT201700460T1/it unknown
- 2012-03-02 HR HRP20171579TT patent/HRP20171579T8/hr unknown
- 2012-03-02 NO NO12751994A patent/NO2680873T3/no unknown
- 2012-03-02 DK DK12751994.0T patent/DK2680873T3/en active
- 2012-03-02 CA CA2865791A patent/CA2865791C/en active Active
- 2012-03-02 WO PCT/US2012/027451 patent/WO2012119065A2/en not_active Ceased
- 2012-03-02 JP JP2013556894A patent/JP5809296B2/ja active Active
- 2012-03-02 PL PL12751994T patent/PL2680873T3/pl unknown
- 2012-03-02 PT PT127519940T patent/PT2680873T/pt unknown
- 2012-03-02 HU HUE12751994A patent/HUE036778T2/hu unknown
- 2012-03-02 ES ES12751994.0T patent/ES2645074T3/es active Active
- 2012-03-02 CA CA 3053850 patent/CA3053850A1/en not_active Abandoned
- 2012-03-02 CN CN201610692359.9A patent/CN106279369B/zh active Active
- 2012-03-02 CN CN201280021321.9A patent/CN103889221B/zh active Active
- 2012-03-02 RS RS20171032A patent/RS56426B1/sr unknown
- 2012-03-02 LT LTEP12751994.0T patent/LT2680873T/lt unknown
- 2012-03-02 EP EP17158336.2A patent/EP3192803B1/en active Active
- 2012-03-02 EP EP12751994.0A patent/EP2680873B1/en active Active
2013
- 2013-05-03 US US13/886,972 patent/US8722619B2/en active Active
2014
- 2014-04-01 US US14/242,192 patent/US9217014B2/en active Active
2015
- 2015-09-10 JP JP2015178029A patent/JP6111447B2/ja active Active
- 2015-11-24 US US14/950,801 patent/US9676821B2/en active Active
2017
- 2017-02-16 JP JP2017026954A patent/JP6302108B2/ja active Active
- 2017-05-18 US US15/598,913 patent/US20170253635A1/en not_active Abandoned
- 2017-10-23 CY CY20171101099T patent/CY1119709T1/el unknown
2018
- 2018-03-01 JP JP2018036159A patent/JP2018118977A/ja active Pending
2021
- 2021-07-01 US US17/365,188 patent/US12344680B2/en active Active
2024
- 2024-06-19 LT LTPA2024520C patent/LTPA2024520I1/lt unknown
- 2024-06-19 FI FIC20240022C patent/FIC20240022I1/fi unknown
- 2024-06-19 CY CY2024022C patent/CY2024022I2/el unknown
- 2024-06-20 FR FR24C1027C patent/FR24C1027I2/fr active Active
- 2024-06-20 HU HUS2400021C patent/HUS2400021I1/hu unknown
- 2024-06-21 NL NL301280C patent/NL301280I2/nl unknown
2025
- 2025-06-03 US US19/226,762 patent/US20250289852A1/en active Pending

Also Published As

Publication number	Publication date
JP6111447B2 (ja)	2017-04-12
PL2680873T3 (pl)	2018-01-31
US20130244930A1 (en)	2013-09-19
JP6302108B2 (ja)	2018-03-28
SMT201700460T1 (it)	2018-01-11
HRP20171579T8 (hr)	2018-12-14
SI2680873T1 (sl)	2017-12-29
US20170253635A1 (en)	2017-09-07
NO2680873T3 (pt)	2018-01-06
US20150024997A1 (en)	2015-01-22
US20250289852A1 (en)	2025-09-18
JP2017132770A (ja)	2017-08-03
EP2680873B1 (en)	2017-08-09
FR24C1027I2 (fr)	2025-05-23
CN103889221A (zh)	2014-06-25
HUE036778T2 (hu)	2018-07-30
EP2680873A2 (en)	2014-01-08
EP3192803B1 (en)	2020-12-09
ES2645074T8 (es)	2018-09-28
US8722619B2 (en)	2014-05-13
DK2680873T3 (en)	2017-10-30
NL301280I2 (nl)	2024-08-01
US12344680B2 (en)	2025-07-01
CN103889221B (zh)	2016-08-31
JP2014516339A (ja)	2014-07-10
FR24C1027I1 (fr)	2024-08-30
WO2012119065A2 (en)	2012-09-07
HUS2400021I1 (hu)	2024-07-28
CA2865791C (en)	2019-10-08
LT2680873T (lt)	2017-11-27
LTPA2024520I1 (pt)	2024-07-10
JP2016029052A (ja)	2016-03-03
JP5809296B2 (ja)	2015-11-10
CN106279369A (zh)	2017-01-04
US9676821B2 (en)	2017-06-13
FIC20240022I1 (fi)	2024-06-19
RS56426B1 (sr)	2018-01-31
CY2024022I1 (el)	2025-03-28
WO2012119065A3 (en)	2014-03-13
JP2018118977A (ja)	2018-08-02
CA2865791A1 (en)	2012-09-07
US20160075740A1 (en)	2016-03-17
US20220162263A1 (en)	2022-05-26
CY1119709T1 (el)	2018-06-27
CY2024022I2 (el)	2025-03-28
EP3192803A1 (en)	2017-07-19
ES2645074T3 (es)	2017-12-04
CA3053850A1 (en)	2012-09-07
CN106279369B (zh)	2020-02-11
HRP20171579T1 (hr)	2018-02-09
US9217014B2 (en)	2015-12-22
EP2680873A4 (en)	2015-08-26

Publication	Publication Date	Title
HUS2400021I1 (hu)	2024-07-28	Gombaellenes szerek és alkalmazásuk
IL233051B (en)	2019-02-28	Anti-phf-tau antibodies and uses thereof
EP2552953A4 (en)	2013-09-04	FRIZZLED-BINDING SUBSTANCES AND ITS USES
IL230511A0 (en)	2014-03-31	4-Imidazopyridazine-1-yl-benzamides and 4-imidazotriazine-1-yl-benzamides as btk inhibitors
IL229844B (en)	2022-02-01	Anti-psgl-1 antibodies and their use
GB201105418D0 (en)	2011-05-18	Pesticide
ZA201403372B (en)	2017-08-30	Therapeutic agents and uses thereof
GB201111705D0 (en)	2011-08-24	Compounds and their use
IL231082A (en)	2016-09-29	Pyrimido compounds - pyridazinone and their use
ZA201305718B (en)	2014-10-29	Topical antifungal agent
EP2688412A4 (en)	2014-10-08	INSECTICIDES AND APPLICATIONS THEREOF
PL2667710T3 (pl)	2017-10-31	Kompozycja owadobójcza i związane z nią sposoby
GB201106357D0 (en)	2011-06-01	Composition and uses thereof
EP2716359A4 (en)	2014-04-23	COMPLEX AND USES THEREOF
GB201111775D0 (en)	2011-08-24	Compounds and uses thereof
GB201114448D0 (en)	2011-10-05	Compounds and their use
EP2776064A4 (en)	2015-08-05	ANTAGONISTS OF PRO-VASOPRESSIN AND USES THEREOF
EP2704579A4 (en)	2014-11-05	SCRAP CONTROL AND APPLICATIONS THEREOF
EP2605770A4 (en)	2014-12-10	ANTIFUNGAL AGENTS AND USES THEREOF
PL2595961T3 (pl)	2017-10-31	Benzocykloalkeny jako środki przeciwgrzybicze
GB201007471D0 (en)	2010-06-16	Antifungal agent
GB201121726D0 (en)	2012-02-01	Compounds and uses thereof
GB201121551D0 (en)	2012-01-25	Compounds and uses thereof
GB201120454D0 (en)	2012-01-11	Kit and uses thereof
GB201104444D0 (en)	2011-04-27	Compounds and their use